Getting Personal with Diabetes Care


We have a diverse selection of pharmacotherapy options for blood glucose management.  Which one should people with diabetes choose? That’s a case-by-case decision—all depending on the individual. In this session, find out how and why we’re saying goodbye to algorithms and ushering in personalized approaches to help people with diabetes reach their glycemic goals. 

This session is part of the Trending Topics in Ambulatory Care series and  provides a robust preparatory curriculum for the high-level pharmacy professional planning to take the BCACP examination or for those seeking BCACP recertification credit.

Pharmacist Learning Objectives

At the completion of this application-based activity, participants will be able to:

  1. Describe the 11 pathways that lead to hyperglycemia and how this impacts the diagnosis and treatment of diabetes.
  2. Compare the various noninsulin pharmacotherapy agents for management of diabetes.
  3. Formulate a person-centered diabetes treatment plan considering the A1C target, concurrent conditions, and “egregious 11.”
Susan Cornell, PharmD, BS, FAPhA
Associate Professor
Midwestern University
Sneha Srivastava, PharmD, BCACP, CDE, DipACLM
Associate Professor
Rosalind Franklin University of Medicine and Science
Learning Level: Level 3
Track: Ambulatory Care, Community-Based Pharmacy Practice, Pharmacist Clinical Patient Care Services
Session Time Slot(s): 
Friday, March 20
1:30 PM - 3:30 PM
Gaylord National - National Harbor 12-13
ACPE Pharmacist: 0202-0000-20-036-L01-P
CEUs Pharmacist: 0.2
Activity Type: